thinkstockJanuary 7, 2015: Markets opened higher on Wednesday after ADP and TrimTab reports on unemployment came in a shade above expectations. The U.S. trade balance improved in November primarily on the drop…
A new resort from UBS highlights the firm's first Equity Focus list for 2015. Here are five of the highest yielding dividend stocks on the list.
Monday's top analyst upgrades, downgrades and initiations include Akamai Technologies, Carnival, Chevron, El Pollo Loco, Ford, F5 Networks, Lululemon Athletica and Starbucks.
In a new research report, the SunTrust Robinson Humphrey team highlights the top pharmaceutical stocks to buy for 2015.
With investors loving dividends so much, 24/7 always tries to take a look at what the Dogs of the Dow will look like for the year ahead.
24/7 Wall St. has compiled a list health care stocks that Merrill Lynch expects to be top performers in 2015.
thinkstockDecember 15, 2014: Markets opened higher on Monday following a strong report on industrial production that was later describe as a catch-up phase from previous growth. But the big drag appears to…
thinkstockDecember 9, 2014: Markets opened lower on Tuesday following a sharp decline overnight in the Shanghai Composite after China’s central bank tightened up liquidity restrictions. A better than expected job openings report…
SunTrust Robinson Humphrey analysts say in a research note that Achaogen and Cempra could be in play as acquisition targets.
Lee Jackson Merck will acquire Cubist for $102 a share, or, about $9.5 billion, including $1.1 billion in Cubist’s net debt and other items.
Paul Ausick Monday may have started out as a fairly quiet news day for most stock sectors on a shortened week, but don't tell that to the Ebola drug stocks.
For the third consecutive year, the company spending the most on research and development (R&D) was Germany's Volkswagen.
thinkstockNovember 14, 2014: Markets opened mixed on Friday following a jump in U.S. consumer sentiment coupled with better-than-expected reports on eurozone GDP. Even oil is performing better today, likely due to the…
A new research report from the analysts at UBS focuses on four companies that stand to benefit from rising demand for the drugs they produce that treat hepatitis C.
thinkstockOctober 30, 2014: Markets opened mixed again on Thursday with the DJIA opening higher on the strength of a big earnings beat by the index’s most influential component. The first estimate of…
